Case 1: Use of Maintenance Therapy in Ovarian Cancer

Management strategies for one adverse event from experienced nurse practitioners: Episode 2Подробнее

Ovarian Cancer | Cases from the Community: Investigators Discuss Available Research Guiding the C...Подробнее

Management strategies for one adverse event from experienced nurse practitioners: Episode 3Подробнее

3/26/2021: Upfront Treatment of Advanced Ovarian Cancer; Ay, Now the Plot ThickensПодробнее

Updates in Ovarian Cancer: Frontline MaintenanceПодробнее

Binaytara Foundation Multidisciplinary Molecular Tumor Board - Ovarian Cancer - November 1st, 2020Подробнее

Learn all about PARP inhibitors with Dr Jon Krell, Consultant Medical OncologistПодробнее

PARP inhibitors in ovarian cancer: Clinical updates from SGO 2023Подробнее

Management strategies for one adverse event from experienced nurse practitioners: Episode 1Подробнее

Latest updates in low grade serous ovarian cancer treatment and researchПодробнее

Case 1: Use of Niraparib in Ovarian CancerПодробнее

Case 1: Impact of Biomarkers on Maintenance TherapyПодробнее

Dr. Krishnansu Tewari: Ovarian Cancers- Epithelial Tumors of the PelvisПодробнее

Case 2: Olaparib in BRCA-Mutated Ovarian CancerПодробнее

Case 3: Benefit of PARP Inhibitor Maintenance in Ovarian CancerПодробнее

Case 1: Use of Niraparib in Ovarian CancerПодробнее

Case 1: Observation Versus Maintenance Therapy in Ovarian CancerПодробнее

Case 1: Diagnostic Tissue Testing in Ovarian CancerПодробнее